| Open-market activity | Bought | Sold | Net | Trades |
|---|---|---|---|---|
| Last 3 months | ₹0 | ₹0 | ₹0 | 0 buys, 0 sales |
| Last 6 months | ₹0 | ₹0 | ₹0 | 0 buys, 0 sales |
| Last 12 months | ₹0 | ₹0 | ₹0 | 7 buys, 0 sales |
Open-market = purchases on the market and sales on or off the market. ESOP exercises, gifts, transfers inside the promoter group and pledges are listed below but not counted as buying or selling. Latest filing 1 Apr 2026.
| Reported | Promoter | Event | Lender / detail | Shares | Of company | Total encumbered |
|---|---|---|---|---|---|---|
| 17 Feb 2026 | Espee Therapeutics LLP | Creation | Bajaj Finance Limited | 400,000 | 0.87% | 0.00% |
| 16 Feb 2026 | Renosen Pharmaceuticals Private Ltd | Release | Bajaj Finance Limited | 400,000 | 0.87% | 0.87% |
| 4 Dec 2025 | Renosen Pharmaceuticals Private Ltd | Creation | Bajaj Finance Limited | 400,000 | 0.87% | 0.00% |
| 4 Dec 2025 | Renosen Pharmaceuticals Private Ltd | Creation | Bajaj Finance Limited | 400,000 | 0.87% | 0.00% |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
